Risk factors for neuropathic pain in diabetes mellitus

Harry L. Hébert (Lead / Corresponding author), Abirami Veluchamy, Nicola Torrance, Blair H. Smith

Research output: Contribution to journalReview article

17 Citations (Scopus)
141 Downloads (Pure)
Original languageEnglish
Pages (from-to)560-568
Number of pages9
JournalPain
Volume158
Issue number4
Early online date30 Dec 2016
DOIs
Publication statusPublished - 1 Apr 2017

Keywords

  • Neuropathic pain
  • Diabetes
  • Neuropathy
  • Risk factors
  • Painful diabetic neuropathy
  • Review

Cite this

Hébert, Harry L. ; Veluchamy, Abirami ; Torrance, Nicola ; Smith, Blair H. / Risk factors for neuropathic pain in diabetes mellitus. In: Pain. 2017 ; Vol. 158, No. 4. pp. 560-568.
@article{ac0ff46c2de0452c9b8253422042936a,
title = "Risk factors for neuropathic pain in diabetes mellitus",
keywords = "Neuropathic pain, Diabetes, Neuropathy, Risk factors, Painful diabetic neuropathy, Review",
author = "H{\'e}bert, {Harry L.} and Abirami Veluchamy and Nicola Torrance and Smith, {Blair H.}",
note = "B.H.S. is a member of the DOLORisk consortium which is funded by the European Commission Horizon 2020 (ID: 633491) and is partly supported by this grant. He has received, on behalf of his institution, occasional lecture and consultancy fees from Pfizer Ltd, Napp Pharmaceuticals, Grunenthal and Eli Lilly.",
year = "2017",
month = "4",
day = "1",
doi = "10.1097/j.pain.0000000000000785",
language = "English",
volume = "158",
pages = "560--568",
journal = "Pain",
issn = "0304-3959",
publisher = "Lippincott, Williams & Wilkins",
number = "4",

}

Risk factors for neuropathic pain in diabetes mellitus. / Hébert, Harry L. (Lead / Corresponding author); Veluchamy, Abirami; Torrance, Nicola; Smith, Blair H.

In: Pain, Vol. 158, No. 4, 01.04.2017, p. 560-568.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Risk factors for neuropathic pain in diabetes mellitus

AU - Hébert, Harry L.

AU - Veluchamy, Abirami

AU - Torrance, Nicola

AU - Smith, Blair H.

N1 - B.H.S. is a member of the DOLORisk consortium which is funded by the European Commission Horizon 2020 (ID: 633491) and is partly supported by this grant. He has received, on behalf of his institution, occasional lecture and consultancy fees from Pfizer Ltd, Napp Pharmaceuticals, Grunenthal and Eli Lilly.

PY - 2017/4/1

Y1 - 2017/4/1

KW - Neuropathic pain

KW - Diabetes

KW - Neuropathy

KW - Risk factors

KW - Painful diabetic neuropathy

KW - Review

U2 - 10.1097/j.pain.0000000000000785

DO - 10.1097/j.pain.0000000000000785

M3 - Review article

C2 - 27941499

VL - 158

SP - 560

EP - 568

JO - Pain

JF - Pain

SN - 0304-3959

IS - 4

ER -